Clinical trials are the springboard for progress in modern healthcare, guiding the development and evaluation of new treatments and next-generation therapies for patients. Trials exist at the critical juncture where scientific innovation meets real-world patient care and offer the promise of improved health outcomes and an enhanced quality of life. Yet as innovative as clinical trials are, the industry itself is still ripe for innovation from within. The structure and setup of clinical trials, coupled with the technologies that facilitate them, play a pivotal role in shaping their success or failure.
“Efficiency is crucial at every point in the drug development process“
The choices made in trial setup—from patient recruitment strategies to data collection methods—directly impact the success and cost of a trial. Efficiency is crucial at every point in the drug development process. The industry has moved from paper-based data collection methods to the use of electronic data capture (EDC) systems and healthcare providers have moved to electronic health records (EHRs). While these EHRs and EDC systems are digital, the connection between them mainly is not digital, but analog. This non-digital connection creates an opportunity for innovative approaches using technology to better streamline trial processes, enhancing data accuracy, reducing cost, and expediting the development of new therapies. Download the white paper below to read in full.
